VCYT Veracyte Diagnostics: Year-over-year earnings per share growth for the last twelve months

Graphic logo of Veracyte, Inc. (VCYT)

Veracyte, Inc. (VCYT) is confidently capturing the molecular diagnostics niche driven by test accuracy and insurance provider support. This quarterly earnings per share growth chart in the GURU.Markets terminal shows that the current parameter is 58.30. High margins are sustained by AI algorithms that automate analysis, although aggressive competition from medtech behemoths and startups forces the company to continuously refine its genetic research.

VCYT: Veracyte Earnings per share growth in annualized terms for the last twelve months 07/04/2022 - 11/12/2026

Summary analytical data breakdowns for Veracyte Diagnostics (VCYT)

- share price and expert price forecast:
Stock Price Veracyte|VCYT - Analyst Consensus Forecast
- company stock capitalization data:
Market Value Veracyte Corp|VCYT - Total Company Value
- book capitalization data:
Accounting Value per Share Veracyte|VCYT - Total Stockholders' Equity|Market Value to Book Value Ratio veracyte.com|VCYT - Company Total Asset Base
- debt burden and liquidity indicators:
Total Debt to Capital Veracyte, Inc.|VCYT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Veracyte, Inc.|VCYT - Company Total Debt Obligations|Debt to Book Value Veracyte Corp|VCYT - Company Long-Term Debt|Company Short-Term Debts Veracyte|Quick Liquidity veracyte.com
- earnings and valuation multiples information:
VCYT - Final Profit|Projected Future Earnings Veracyte, Inc.|VCYT - P/E Multiple|Forward P/E Multiple Veracyte Corp|VCYT - Price/Earnings to Growth Multiple|Enterprise Value to EBITDA Ratio Veracyte Corp|VCYT - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Veracyte|VCYT - Earnings per share for the last four quarters|Quarterly EPS earnings growth veracyte.com|VCYT - Earnings per share growth rate in current year|Expected earnings per share growth for next year Veracyte, Inc.
Analysis of all company metrics:Veracyte, VCYT
Flagship merchandise of Veracyte, Inc.

Veracyte, Inc. (VCYT) maintains stability through molecular tests integrated into medical standards, which generate a steady stream of orders. Quarterly EPS growth measures the rate of change in net income per share, reflecting the efficiency of the business's capitalization. Investors evaluate this indicator to identify hidden vulnerabilities and avoid overpaying for the asset. The smoothed line filters out market noise, confirming the issuer's fundamental strength. Analysis of this quarterly EPS chart allows for an objective assessment of the company's long-term profitability.

Direct competitors

CAI: Quarterly EPS earnings growth|Guardant Health Inc (GH) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Celcuity Corp|Year-over-year earnings per share growth for the last twelve months GRAL|Year-over-year net earnings per share growth for the last 12 months MYGN (Myriad Genetics, Inc.)|CSTL - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Burning Rock BNR|Year-over-year net earnings per share change for the last twelve months VolitionRx Ltd. (VNRX)|Biodesix Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Precipio Inc PRPO|check-cap.com (CHEK) - Year-over-year earnings per share growth for the last twelve months|MYNZ - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OCX